-
GPhC Consultation – Setting Standards
January 2010
The PDA believes that the proposals contained within the initial GPhC consultation fall short of our expectations. Our response to the consultation is provided in several parts.
-
Vote for these candidates to deal a blow to Remote Supervision
Tue 15th December 2009
We are being told that the profession demands a debate about Remote Supervision, but by whom? Some senior figures working for large multiples are keen to see the supervision rules 'changed' - but why? When the PDA first suggested that the multiples would use Remote Supervision to allow them to run…
-
Delaying the Responsible Pharmacist Regulations
Mon 27th July 2009
Two weeks ago the PDA established a membership survey to assess how pharmacists felt about the impending October 1st RP implementation deadline. Already more than 2,500 pharmacists have responded providing some worrying statistics. 93% of those responding to the survey have stated that the profession will simply not be ready.
-
Decriminalisation of dispensing errors; encouraging early campaign results
Tue 16th June 2009
The PDA has regularly communicated progress on its campaign to decriminalise dispensing errors to its members. It is pleased to announce that there has been a significant breakthrough in moving toward achieving its campaign objectives.
-
Disciplined for a single dispensing error
February 2009
This article reflects on the implications of the new Responsible Pharmacist regulations in the event that a pharmacist is disciplined by their employer for dispensing errors.
-
Which? Report Slates Remote Supervision
December 2008
Concerns about the proposal to allow a pharmacy to operate in the absence of a pharmacist have been raised consistently by the PDA, which has always contended that the proposals to let pharmacy staff run a pharmacy, without a pharmacist present, are being pushed through without proper debate
-
Lessons Learned from the Peppermint Water Case
Mon 21st July 2003
What can be learned from 'The Peppermint Water Case'? Alan Nathan FRPharmS, a member of the Royal Pharmaceutical Society's Council until May 2002 and a former Chairman of its Councils Infringement Committee gives its views on the way this high profile case was dealt with.